Punching above its weight

Candesic came into being in 2002. Along with a crew of other McKinsey alumni, Dr Shapiro set about the task of creating a firm that would provide services more efficiently and with more in-depth insight than conventional top consultancies, thus appealing to specialized operators and investors that might not have previously considered using the services of an outside party. 

Today, Candesic has four partners, three of whom worked previously for McKinsey. Candesic works with a range of companies, from small independents to the bigger hitters in the healthcare sector.

The company quickly picked up an impressive array of international corporate and investor clients including leading global private equity funds as well as well-established corporate operators.

A healthy dose of consultancy

Since starting its healthcare and life sciences due diligence practice, Candesic has become an expert in the field. The partners work alongside a team that includes medical doctors, scientists and business experts. The consultancy looks at investments of between €10 million and €1+ billion. The firm also gives advice on growth strategy and market entry strategy to corporates and portfolio companies of investors. In the last five years, Candesic was awarded multiple times “Strategy Consultancy of the Year” and “Consultants of the year - Transactional” by HealthInvestor, “Commercial Due Diligence Provider of the Year” by RealDeals and LaingBuisson’s “Management Consultant of the Year”.

Everyone benefits

Candesic’s clients, employees, and the broader healthcare ecosystem are all beneficiaries of the company’s focus on providing advice based on deep medical and science knowledge that helps advance the clients’ missions of improving patient care.